SOPH 财务： SOPHiA GENETICS SA AI 分析

主页

股票

SOPH

SOPH 财务

SOPHiA GENETICS SA

$4.8

1.05%

$0.04

截至今日：Feb 13, 12:47:04 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$4.75

开盘价

$4.75

当日区间

$4.72 - $4.85

52周范围

$2.58 - $5.7

交易量

51.6K

平均成交量

172.4K

每股收益（TTM）

-1.12

股息收益率

市值

$325.6M

什么是 SOPH？

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 423 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

SOPH 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	73	65	62	47	40	28
营收同比增长 (YoY)	14%	5%	32%	18%	43%	12%
营收成本	23	21	19	16	15	10
毛利润	49	43	42	31	25	17
销售、一般及管理费用	83	76	77	81	68	34
研发	34	34	34	33	25	17
营业费用	118	110	117	119	96	55
其他非经营性收入 (费用)	0	0	0	0	0	0
税前利润	-72	-61	-78	-87	-73	-41
所得税费用	2	1	0	0	0	-1
净利润	-74	-62	-78	-87	-73	-39
净利润增长	4%	-21%	-10%	19%	87%	18%
稀释后流通股数	67.78	66.06	64.75	64.1	55.3	63.34
股份同比变动 (YoY)	2%	2%	1%	16%	-13%	0%
每股收益 (摊薄)	-1.11	-0.94	-1.21	-1.36	-1.33	-0.62
每股收益增长率	3%	-22%	-10%	2%	114.99%	17%
自由现金流	-46	-50	-57	-80	-64	-34
每股自由现金流	--	--	--	--	--	--
毛利率	67.12%	66.15%	67.74%	65.95%	62.5%	60.71%
营业利润率	-93.15%	-101.53%	-119.35%	-185.1%	-177.5%	-132.14%
净利率	-101.36%	-95.38%	-125.8%	-185.1%	-182.5%	-139.28%
自由现金流利润率	-63.01%	-76.92%	-91.93%	-170.21%	-160%	-121.42%
EBITDA	-59	-58	-66	-82	-68	-35
EBITDA 利润率	-80.82%	-89.23%	-106.45%	-174.46%	-170%	-125%
EBITDA 中的折旧与摊销	9	8	8	5	3	2
EBIT	-68	-66	-74	-87	-71	-37
EBIT 利润率	-93.15%	-101.53%	-119.35%	-185.1%	-177.5%	-132.14%
有效税率	-2.77%	-1.63%	0%	0%	0%	2.43%

SOPHiA GENETICS SA（SOPH）价格

SOPH 股价走势图